To view more details, including parent strains and references, click on the corresponding dictyBase ID.
| Systematic Name | Strain Descriptor | Associated gene(s) | Phenotypes |
|---|---|---|---|
| DBS0266721 | Dd5P4-/ [act15]: Hs-OCRL(D422A) | Dd5P4 | decreased phagocytosis |
| DBS0237041 | VatMpr | vatM | increased protein localization to cytoplasm | decreased phagocytosis | decreased growth rate | aberrant regulation of intracellular pH |
| DBS0237236 | [AS]: [tet]: trrA | trrA | decreased growth rate | delayed development | abolished aggregation |
| DBS0350570 | [AS]PARP | DDB_G0286613 | DDB_G0289141 | adprt1A | adprt1B | adprt2 | adprt3 | adprt4 | pARTf | pARTg | decreased cell death | aberrant positive regulation of mitochondrial membrane potential |
| DBS0350559 | [AS]act15: adprt1A | adprt1A | development arrests at loose mound stage | decreased gene expression | decreased ATP level | increased mitochondrial fission |
| DBS0351092 | [AS]aif | aif | aberrant cellular homeostasis | aberrant regulation of mitochondrial membrane potential | aberrant mitochondrion morphology | decreased ATP level | increased gene expression | decreased gene expression | decreased growth rate | aberrant cell cycle | increased necrotic cell death | delayed development | aberrant response to oxidative stress | aberrant cell morphology | increased mitochondrial fission | aberrant mitochondrion organization |
| DBS0304456 | [AS]alrA/ gcsA- | alrA | gcsA | aberrant cellular metabolic process | increased gene expression | decreased growth rate | mitotic G1 phase arrest |
| DBS0237273 | [AS]calA | calA | abolished cytokinesis |
| DBS0350897 | [AS]carA | carA-1 | carA-2 | abolished aggregation |
| DBS0237228 | [AS]cfrA/ [AS]cfrB | cfrA | cfrB | decreased sexual fusion |
| DBS0237224 | [AS]cmfA | cmfA | abolished aggregation |
| DBS0237225 | [AS]cupB | cupB | abolished aggregation |
| DBS0350979 | [AS]deeJ | deeJ | decreased pinocytosis | decreased phagocytosis | aberrant fruiting body morphogenesis |
| DBS0237226 | [AS]dia1 | dia1 | decreased gene expression | precocious aggregation |
| DBS0351176 | [AS]dscA | dscA-1 | dscA-2 | abolished stream development |
| DBS0238235 | [AS]dutA | dutA | wild type |
| DBS0350560 | [AS]ecmB: adprt1A | adprt1A | development arrests at slug stage |
| DBS0350676 | [AS]erkA | erkA | aberrant vegetative growth |
| DBS0237229 | [AS]gpaA | gpaA | wild type |
| DBS0351057 | [AS]gshB | gshB | increased slug migration |
| HPF414 | [AS]hspA | hspA | decreased growth rate | aberrant fruiting body morphogenesis | decreased defense response to bacterium |
| DBS0351041 | [AS]hspA/ [AS]ndkC-1 | hspA | ndkC-1 | ndkC-2 | wild type |
| DBS0238749 | [AS]hspA/ snfA | hspA | snfA | wild type |
| DBS0252819 | [AS]hssA | hssA | wild type |
| DBS0351171 | [AS]htrA | htrA | decreased growth rate | aberrant fruiting body morphogenesis |
| DBS0237230 | [AS]ino1 | ino1 | abolished vegetative growth |
| DBS0236725 | [AS]patA | patA | decreased growth rate |
| DBS0237504 | [AS]pikE | pikE | aberrant stalk morphogenesis | decreased growth rate |
| DBS0237232 | [AS]proA | proA | wild type |
| DBS0350355 | [AS]proA-/ proB-/ lmpA- | lmpA | proA | proB | abolished sporulation | wild type |
| DBS0351311 | [AS]proA/ abpB(129-295) | abpB | proA | aberrant cellular process |
| DBS0236827 | [AS]proA/ proB- | proA | proB | decreased exocytosis | decreased pinocytosis | aberrant exocytosis | increased actin filament polymerization | development arrests at slug stage | aberrant cytokinesis | decreased cell motility | abolished vegetative growth | decreased secretion of lysosomal enzymes | increased phagocytosis |
| DBS0238036 | [AS]proA/ proB-/ [act15]: proA | proA | proB | wild type |
| DBS0238037 | [AS]proA/ proB-/ [act15]: proB | proA | proB | wild type |
| DBS0350334 | [AS]proA/ proB-/ scrA- | proA | proB | scrA | decreased exocytosis | decreased pinocytosis | decreased secretion of lysosomal enzymes |
| DBS0350117 | [AS]ptcB | ptcB | decreased growth rate |
| DBS0236851 | [AS]rapA | rapA | decreased pinocytosis | aberrant osmosensory signaling pathway | decreased phagocytosis | abolished vegetative growth | increased actin phosphorylation | aberrant hyperosmotic response |
| DBS0351303 | [AS]rheb | rheb | decreased growth rate | increased macropinocytosis | increased phagocytosis |
| DBS0350574 | [AS]rps4 | rps4 | decreased spore germination | aberrant actin cytoskeleton organization | aberrant vegetative growth | decreased mound size | decreased spore size | aberrant fruiting body morphogenesis | decreased sporulation |
| DBS0236904 | [AS]rps4 | mrps4 | delayed aggregation | aberrant fruiting body morphogenesis |
| DBS0238748 | [AS]snfA | snfA | decreased number of mitochondria | decreased ATP level | increased growth rate | decreased fruiting body size | aberrant mitochondrion organization |
| DBS0304498 | [AS]sslA1 | sslA1 | decreased fruiting body size |
| DBS0237235 | [AS]tcp1 | tcp1 | decreased growth rate | development arrests at mound stage | aberrant fruiting body morphogenesis |
| DBS0351302 | [AS]tpp1 | tpp1 | aberrant cellular process | decreased growth rate | aberrant sorocarp development | increased macropinocytosis | increased phagocytosis |
| DBS0351218 | [AS]twm1 | twm1 | decreased growth rate |
| DBS0350649 | [AS]vatB | vatB | delayed aggregation | aberrant slug migration | aberrant response to chemical |
| DBS0306101 | [AS]vatP | vatP | decreased calcium ion import | decreased growth rate |
| DBS0306102 | [AS]vatP | vatP | decreased calcium ion import | decreased growth rate | delayed development |
| DBS0350519 | [OE]: egeA | egeA | decreased protein level | abolished aggregation |
| DBS0350172 | [RNAi]allC | allC | development arrests at loose mound stage | decreased protein level | decreased gene expression | decreased vegetative cell size | increased growth rate |
| DBS0350070 | [RNAi]canA | canA | aberrant sorus morphology | aberrant response to cation stress | increased defense response to Gram-negative bacterium | decreased fruiting body size | decreased stalk length |
| DBS0350727 | [RNAi]cepE | cepE | increased number of centrosomes | aberrant cell separation during cytokinesis | aberrant mitotic sister chromatid segregation |
| DBS0235409 | [RNAi]cnbA | cnbA | aberrant sorus morphology | decreased gene expression | aberrant response to cation stress | increased defense response to Gram-negative bacterium | aberrant stalk cell differentiation | decreased stalk length |
| DBS0349787 | [RNAi]ctnnA | ctnnA | abolished epithelium-like organization | abolished stalk development | aberrant protein secretion | abolished establishment of cell polarity | aberrant Golgi localization | aberrant centrosome localization | abolished culmination | aberrant protein localization |
| DBS0349923 | [RNAi]ctnnA/ [act15]: GFP-mhcA | ctnnA | aberrant stalk morphogenesis | decreased epithelium-like organization | aberrant protein localization |
| DBS0237295 | [RNAi]fimA | fimA | wild type |
| DBS0349944 | [RNAi]fttB | fttB | increased number of mound tips | aberrant cytokinesis | decreased growth rate | delayed development | decreased chemotaxis to cAMP | aberrant cytoskeleton organization |
| DBS0252820 | [RNAi]hssA | hssA | wild type |
| DBS0350940 | [RNAi]kif6 | kif6 | aberrant mitotic spindle organization |
| DBS0237310 | [RNAi]lipA | lipA | wild type |
| DBS0349871 | [RNAi]lkb1 | lkb1 | abolished prespore cell differentiation | delayed aggregation | aberrant slug development | aberrant sorocarp development | aberrant response to osmotic stress | aberrant response to oxidative stress | aberrant regulation of protein kinase activity | increased prestalk cell differentiation | decreased sporulation |
| DBS0350643 | [RNAi]nse1 | nse1 | aberrant response to UV | aberrant stream morphology | decreased fruiting body size |
| DBS0350644 | [RNAi]nse4 | nse4 | decreased gene expression | aberrant response to UV | aberrant stream morphology | decreased fruiting body size |
| DBS0237296 | [RNAi]pks16 | pks16 | wild type |
| DBS0237311 | [RNAi]racF2 | racF2 | abolished vegetative growth |
| DBS0350488 | [RNAi]rmd1 | rmd1 | aberrant cell separation during cytokinesis |
| DBS0238734 | [RNAi]sdhA | sdhA | abolished aggregation | decreased phototaxis |
| DBS0351295 | [RNAi]sir2D | sir2D | decreased gene expression | delayed development |
| DBS0351599 | [RNAi]srtA | srtA | increased pre-miRNA processing |
| DBS0304564 | [RNAi]sun1 | sun1 | aberrant nucleus morphology | increased vegetative cell size |
| DBS0349929 | [RNAi]tacA | tacA | aberrant response to cation stress | increased gene expression | delayed development | aberrant fruiting body morphogenesis |
| DBS0350046 | [RNAi]tacc | tacc | aberrant response to abiotic stimulus | decreased protein level | decreased size of astral microtubules |
| YLD53 | [RNAi]thg1 | thg1 | decreased growth rate |
| DBS0350794 | [RNAi]tlp3 | tlp3 | decreased growth rate |
| DBS0350795 | [RNAi]tlp4 | tlp4 | decreased growth rate |
| DBS0237818 | [RNAi]wipA | wipA | decreased actin filament polymerization at leading edge | delayed pseudopodium formation | decreased chemotaxis to cAMP | decreased filopodium formation |
| DBS0350924 | [TRE-Pmin]: 6xHis: GFP: dhcA(1384-4725(K1975T)) | dhcA | aberrant molecular function |
| DBS0350052 | [TRE-Pmin]: arfA(Q71L): GFP | arfA | aberrant filopodium formation | aberrant cytokinesis |
| DBS0350053 | [TRE-Pmin]: arfA(T31N): GFP | arfA | wild type | increased defense response to Gram-negative bacterium |
| DBS0237101 | [act15]: CFP: racC(T20N) | racC | decreased actin filament polymerization | aberrant cytokinesis | abolished positive chemotaxis |
| DBS0350908 | [act15]: DD: GFP: rab8A(N128I) | rab8A | increased contractile vacuole size | increased number of contractile vacuoles | abolished protein localization to contractile vacuole |
| DBS0350909 | [act15]: DD: GFP: rab8A(Q74L) | rab8A | aberrant contractile vacuole localization | increased number of contractile vacuoles | decreased contractile vacuole size |
| DBS0350566 | [act15]: FLAG: Rab14(Q67L) | rab14 | increased lysosome size | increased post-lysosomal vacuole size | aberrant phagosome maturation | increased endosomal vesicle fusion |
| DBS0238108 | [act15]: FLAG: ppp4C(H113Q) | ppp4c | development arrests at mound stage | delayed development |
| DBS0351488 | [act15]: FLAG: rasC(Q62L) | rasC | abolished protein localization to plasma membrane | increased actin filament polymerization | decreased chemotaxis to cAMP |
| DBS0304572 | [act15]: GFP: abpD(1441-1736) | abpD | abolished protein localization to nuclear envelope |
| DBS0304571 | [act15]: GFP: abpD(1441-1738) | abpD | abolished protein localization to nuclear envelope |
| DBS0350288 | [act15]: GFP: forF(1-1087) | forF | decreased pinocytosis | decreased phagocytosis | decreased growth rate |
| DBS0350349 | [act15]: GFP: gtaC(1-467: 497-587) | gtaC | abolished protein localization to nucleus |
| DBS0350351 | [act15]: GFP: gtaC(229-587) | gtaC | abolished protein localization to cytoplasm |
| DBS0350359 | [act15]: GFP: gtaC(281-467: 497-587) | gtaC | aberrant protein localization to cytoplasm |
| DBS0350352 | [act15]: GFP: gtaC(281-587) | gtaC | abolished protein localization to cytoplasm |
| DBS0350360 | [act15]: GFP: gtaC(346-467: 497-587) | gtaC | aberrant protein localization to cytoplasm | aberrant protein localization to nucleus |
| DBS0350353 | [act15]: GFP: gtaC(346-587) | gtaC | abolished protein localization to cytoplasm |
| DBS0350350 | [act15]: GFP: gtaC(K469,470,494,496A/ R468,471A) | gtaC | abolished protein localization to nucleus |
| DBS0350337 | [act15]: GFP: pakA(797-1197) | pakA | decreased phagocytosis | decreased cell motility |
| DBS0351073 | [act15]: GFP: rac1A(G12V) | rac1A | decreased growth rate | decreased phagocytosis | aberrant cytokinesis | decreased macropinocytosis | decreased cell motility | delayed development | aberrant actin filament organization | abolished filopodium formation |
| DBS0351074 | [act15]: GFP: rac1C(G12V) | rac1C | decreased growth rate | decreased phagocytosis | aberrant cytokinesis | decreased macropinocytosis | decreased cell motility | delayed development | aberrant actin filament organization | abolished filopodium formation |
| DBS0237132 | [act15]: GFP: racH(T18N) | racH | aberrant cytokinesis | aberrant cell morphology |
| DBS0238393 | [act15]: GFP: rapA(G12V) | rapA | increased cell-substrate adhesion |
| DBS0238394 | [act15]: GFP: rapA(S17N) | rapA | decreased cell-substrate adhesion |
| DBS0350112 | [act15]: GFP: rheb(D60I) | rheb | increased phagocytosis |
| DBS0350111 | [act15]: GFP: rheb(Q64L) | rheb | decreased phagocytosis |
| DBS0351178 | [act15]: GFP: sey1(K154A) | sey1 | increased defense response to Gram-negative bacterium | aberrant catalytic activity | decreased protein localization | aberrant endoplasmic reticulum organization |
| DBS0304563 | [act15]: GFP: sun1(283-905) | sun1 | increased number of centrosomes | decreased protein localization to nuclear envelope | aberrant nuclear membrane organization | aberrant nucleus morphology | increased vegetative cell size | aberrant centrosome localization | aberrant mitotic sister chromatid segregation |
| DBS0350648 | [act15]: HA: Rab14(N121I) | rab14 | decreased pinocytosis | decreased hypotonic response | aberrant contractile vacuole morphology |
| DBS0350899 | [act15]: HA: rab11(N126I) | rab11A | aberrant contractile vacuole organization | aberrant contractile vacuole morphology | increased phagocytosis |
| DBS0350812 | [act15]: HA: rab7A(Q67L) | rab7A | increased exocytosis |
| DBS0350813 | [act15]: HA: rab7A(T22N) | rab7A | decreased pinocytosis | increased secretion of lysosomal enzymes | decreased exocytosis | decreased phagocytosis | aberrant phagosome maturation | abolished macropinocytosis | abolished protein localization to phagocytic vesicle |
| DBS0351228 | [act15]: T7: rasG(G12T) | rasG | increased protein phosphorylation | decreased growth rate | decreased phagocytosis | increased cell-substrate adhesion | decreased filopodium formation |
| DBS0350986 | [act15]: YFP: myoC(G395A) | myoC | decreased pinocytosis | aberrant mitotic spindle organization | decreased phagocytosis |
| DBS0237227 | [act15]: [AS]dia2 | dia2 | aberrant extracellular cAMP signaling pathway | abolished aggregation | decreased cAMP level |
| DBS0349940 | [act15]: acrA(1-731): YFP | acrA | aberrant spore coat morphology | decreased adenylate cyclase activity |
| DBS0238088 | [act15]: atg1(K36A) | atg1 | abolished macroautophagy | increased number of autophagosomes | aberrant cellular response to nitrogen starvation | abolished aggregation |
| DBS0252740 | [act15]: carA(I104D) | carA-1 | carA-2 | increased cAMP binding | delayed aggregation | aberrant oscillatory cAMP signaling | decreased protein kinase activation |
| DBS0252744 | [act15]: carA(I104E) | carA-1 | carA-2 | increased cAMP binding | delayed aggregation | aberrant oscillatory cAMP signaling |
| DBS0252747 | [act15]: carA(I104H) | carA-1 | carA-2 | development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation |
| DBS0252749 | [act15]: carA(I104K) | carA-1 | carA-2 | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation | abolished aggregation |
| DBS0252746 | [act15]: carA(I104N) | carA-1 | carA-2 | development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation |
| DBS0252745 | [act15]: carA(I104Q) | carA-1 | carA-2 | development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation |
| DBS0252750 | [act15]: carA(I104R) | carA-1 | carA-2 | development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation |
| DBS0252748 | [act15]: carA(I104Y) | carA-1 | carA-2 | development arrests at loose mound stage | increased cAMP binding | aberrant oscillatory cAMP signaling | decreased protein kinase activation |
| DBS0237098 | [act15]: cdk5(D144N) | cdk5 | decreased pinocytosis | increased mound size | aberrant protein level | delayed aggregation | decreased phagocytosis | decreased growth rate | decreased sporulation | decreased protein secretion |
| DBS0350946 | [act15]: dhcA(1384-4725) | dhcA | aberrant microtubule cytoskeleton organization |
| DBS0349956 | [act15]: fttB(K49E): GFP | fttB | aberrant cytoskeleton organization |
| DBS0351059 | [act15]: gshB/ [AS]gpaB | gpaB | gshB | aberrant stream morphology | decreased establishment of cell polarity | decreased sporulation |
| DBS0351607 | [act15]: hsp101(K213A) | hsp101 | decreased cellular thermotolerance |
| DBS0351608 | [act15]: hsp101(K613A) | hsp101 | decreased cellular thermotolerance |
| DBS0351173 | [act15]: htrA(S300A) | htrA | decreased growth rate | aberrant fruiting body morphogenesis |
| DBS0350037 | [act15]: mekA(299-360) | mekA | decreased mound size |
| DBS0350034 | [act15]: mekA(K321A) | mekA | decreased mound size |
| DBS0350033 | [act15]: mekA(S444A/ T448A) | mekA | decreased mound size |
| DBS0350332 | [act15]: mkpB(C294V) | mkpB-1 | mkpB-2 | decreased migratory slug size | delayed prestalk gene expression | delayed prespore gene expression | aberrant sorocarp development | decreased resistance to cisplatin |
| DBS0350417 | [act15]: myc: ptpC | ptpC | aberrant protein phosphorylation |
| DBS0266839 | [act15]: myc: ptpCΔ(C649S) | ptpC | aberrant protein localization to nucleus | increased protein tyrosine phosphorylation |
| DBS0266838 | [act15]: myc: ptpC(C649S) | ptpC | aberrant protein localization to nucleus | increased protein tyrosine phosphorylation |
| DBS0238396 | [act15]: myc: rapA(G12V) | rapA | increased protein localization to cell cortex | delayed aggregation | increased cell-substrate adhesion | decreased cell motility | increased protein kinase activation |
| DBS0238397 | [act15]: myc: rapA(S17N) | rapA | decreased cell-substrate adhesion |
| DBS0237183 | [act15]: pakA(K394A) | pakA | development arrests at mound stage | delayed development |
| DBS0237184 | [act15]: pakA[CA] | pakA | abolished aggregation |
| DBS0349855 | [act15]: pakB(1-337: 563-852) | pakB | decreased phagocytosis |
| DBS0237189 | [act15]: pkaR(G135E/ G261A) | pkaR | decreased protein tyrosine phosphorylation | decreased protein kinase activity | abolished cAMP binding | abolished oscillatory cAMP signaling | abolished aggregation |
| DBS0350701 | [act15]: pkaR(G135E/ G261A)/ AX3 | pkaR | decreased gene expression | abolished oscillatory cAMP signaling |
| DBS0350752 | [act15]: pten(C124S): GFP | pten | abolished catalytic activity |
| DBS0350753 | [act15]: pten(G129E): GFP | pten | abolished catalytic activity |
| DBS0350951 | [act15]: rac1B(Q61L) | rac1B | increased lateral pseudopodium formation | decreased chemotaxis to cAMP | aberrant actin filament organization |
| DBS0350952 | [act15]: rac1B(T17N) | rac1B | abolished establishment of cell polarity | delayed aggregation | aberrant actin filament organization | abolished chemotaxis to cAMP |
| DBS0350469 | [act15]: racE(G20V): GFP | racE | decreased actin filament polymerization | aberrant cytokinesis | decreased growth rate |
| DBS0350584 | [act15]: rapA(G12V) | rapA | abolished protein localization to nucleus | increased protein localization to cell cortex | aberrant nucleus morphology | decreased growth rate | aberrant cytokinesis | increased cell-substrate adhesion | abolished protein localization to centrosome | increased number of microtubule organizing center |
| DBS0351497 | [act15]: rasD(Q61L) | rasD | decreased protein kinase activation |
| DBS0351496 | [act15]: rasD(S17N) | rasD | increased protein kinase activation |
| DBS0351212 | [act15]: rasG(S17N) | rasG | aberrant activation of GTPase activity | decreased chemotaxis to cAMP |
| DBS0350671 | [act15]: regA(126-316): myc | regA | precocious sporulation |
| DBS0349793 | [act15]: sadA(921-952) | sadA | decreased cell-substrate adhesion |
| DBS0351040 | [act15]: snfA(1-379): GFP/ [AS]ndkC-1 | ndkC-1 | ndkC-2 | snfA | wild type |
| DBS0349984 | [act6]: GFP: lmnB(1-712) | lmnB | aberrant cellular response to fluid shear stress | aberrant intermediate filament organization | abolished vegetative growth |
| DBS0351551 | [act6]: GFP: lmnB(1-712)/ S122A | lmnB | aberrant intermediate filament bundle assembly |
| DBS0350498 | [act6]: GFP: rab2A(N118I) | rab2A | aberrant cell-cell adhesion | aberrant hypotonic response | increased growth rate | precocious development |
| DBS0350499 | [act6]: GFP: rab2A(Q64L) | rab2A | decreased autophagic cell death | aberrant cell-cell adhesion | aberrant sorocarp development | aberrant hypotonic response | increased growth rate | increased phagocytosis |
| DBS0306243 | [act6]: GFP: sun1 | sun1 | increased number of centrosomes | aberrant nucleus morphology | aberrant mitotic sister chromatid segregation | aberrant centromere complex assembly | aberrant centrosome organization |
| DBS0306244 | [act6]: GFP: sun1(1-722) | sun1 | increased number of centrosomes | aberrant nucleus morphology | aberrant mitotic sister chromatid segregation | aberrant centromere complex assembly | aberrant centrosome organization |
| DBS0237219 | [act6]: ptpC(C649S) | ptpC | increased mound size | decreased growth rate |
| DBS0350807 | [act6]: rabS(N137I): GFP | rabS | increased secretion of lysosomal enzymes | aberrant contractile vacuole organization | increased endocytic recycling |
| DBS0350942 | [disc]: HA: rab14(N121I) | rab14 | decreased endosomal vesicle fusion | decreased phagocytosis |
| DBS0350941 | [disc]: HA: rab14(Q67L) | rab14 | increased lysosome size | increased endosomal vesicle fusion | increased phagocytosis |
| DBS0351492 | [dscA]: His: agtA(D132A) | agtA | aberrant stalk morphogenesis | abolished sporulation |
| DBS0351106 | [dscB]: HA: racC | racC | decreased exocytosis | decreased pinocytosis | decreased macropinocytosis | aberrant actin filament organization | increased phagocytosis |
| DBS0350903 | [dscB]: HA: rapB(G12V) | racB | decreased exocytosis | decreased phagocytosis | aberrant cytokinesis | decreased growth rate | decreased macropinocytosis | aberrant actin filament organization | aberrant cell morphology |
| DBS0350433 | [dscB]: abpB(E60K): GFP | abpB | abolished actin filament polymerization |
| DBS0350820 | [dscB]: cafA | cafA | increased gene expression | precocious development |
| DBS0237237 | [dscB]: cycB(106-436) | cycB | mitotic M phase arrest |
| DBS0350922 | [dscB]: dicA(1-278) | dicA | increased cell death | abolished protein binding | aberrant microtubule cytoskeleton organization | aberrant Golgi localization | aberrant mitotic sister chromatid segregation | aberrant centrosome organization |
| DBS0350923 | [dscB]: dicA(48-654) | dicA | aberrant microtubule cytoskeleton organization | aberrant Golgi localization | decreased protein binding | aberrant mitotic sister chromatid segregation | aberrant centrosome organization |
| DBS0351510 | [dscB]: rac1B(G12V): myc | rac1B | decreased pinocytosis | decreased growth rate | aberrant cytokinesis | delayed development | aberrant actin filament organization | aberrant cell morphology |
| DBS0351511 | [dscB]: rac1B(Q61L): myc | rac1B | decreased growth rate | aberrant cytokinesis | delayed development | aberrant actin filament organization | aberrant cell morphology |
| DBS0351512 | [dscB]: rac1B(T17N): myc | rac1B | decreased pinocytosis | decreased growth rate | aberrant cytokinesis | decreased chemotaxis to folate | delayed development | aberrant actin filament polymerization | aberrant cell morphology |
| DBS0350589 | [dscB]: rapA | rapA | decreased pinocytosis | aberrant actin filament organization | aberrant cell morphology | increased phagocytosis |
| DBS0350586 | [dscB]: rapA(D40E) | rapA | aberrant actin filament organization | aberrant cell morphology |
| DBS0350588 | [dscB]: rapA(F160L) | rapA | aberrant actin filament organization | aberrant cell morphology |
| DBS0350590 | [dscB]: rapA(G12T) | rapA | decreased pinocytosis | increased phagocytosis |
| DBS0350585 | [dscB]: rapA(S19N) | rapA | decreased phagocytosis | aberrant cell morphology |
| DBS0350587 | [dscB]: rapA(T63Q) | rapA | aberrant cell morphology |
| DBS0351230 | [ecmAO]: rasG(G12T) | rasG | aberrant prestalk gene expression | aberrant culmination |
| DBS0350699 | [ecmA]: pkaR(G135E/ G261A) | pkaR | decreased migratory slug size | delayed development of tipped mound | aberrant culmination | aberrant slug migration | decreased prestalk gene expression | increased slug migration | aberrant prestalk cell differentiation |
| DBS0350700 | [ecmA]: pkaR(G135E/ G261A)/ [ecmB-frag]: lacZ | pkaR | abolished stalk cell differentiation |
| DBS0237252 | [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0237253 | [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0349948 | [ndm]: ndm: RFP | ndm | development arrests at mound stage |
| DBS0350697 | [pspA]: pkaR(G135E/ G261A) | pkaR | abolished gene expression | decreased prespore gene expression | aberrant sorus color |
| DBS0351229 | [pspA]: rasG(G12T) | rasG | increased number of mound tips | increased prestalk gene expression | decreased prespore gene expression | abolished phototaxis | increased prestalk cell differentiation |
| DBS0351231 | [rasD]: rasG(G12T) | rasG | development arrests at loose mound stage | increased number of mound tips |
| DBS0236867 | [rasG]: rasG(G12T) | rasG | aberrant aggregation |
| DBS0350110 | [tet]: RNAi: raptor | raptor | decreased growth rate |
| DBS0238351 | [tet]: [RNAi]cinC | cinC | decreased translation | precocious aggregation | decreased growth rate |
| DBS0237318 | [tet]: pten | pten | decreased cell motility | decreased protein kinase activation |
| DBS0237622 | [tet]: rapA(S17N)/ [act15]: gbpD | gbpD | rapA | increased establishment of cell polarity | increased cell-substrate adhesion | aberrant cell morphology |
| DBS0351461 | [tet]rasD(G12T) | rasD | increased gene expression | increased prestalk cell differentiation |
| DBS0351463 | [tet]rasD(G12T)/ rigA- | rasD | rigA | wild type |
| DBS0350494 | [tgrB1]: [RNAi]abcB3/ [tgrC1]: GFP | abcB3 | delayed development | decreased cAMP level |
| DBS0351290 | [tre]: drkA: myc | drkA | decreased growth rate | increased protein tyrosine phosphorylation |
| DBS0304911 | [tre]: paxB | paxB | abolished sporulation | aberrant endocytosis | decreased cell-substrate adhesion | aberrant chemotaxis to folate | development arrests at mound stage | decreased cell motility | increased cell-cell adhesion |
| DBS0350267 | [tre]: secG | secG | increased filopodium formation | abolished establishment of cell polarity | development arrests at mound stage | aberrant actin cytoskeleton organization | aberrant actin filament polymerization | abolished chemotaxis to cAMP | delayed gene expression |
| DBS0351555 | [unk]: FLAG: rab1A(Q67L) | rab1A | aberrant actin filament polymerization | aberrant pseudopodium formation |
| DBS0351556 | [unk]: FLAG: rab1A(S22N) | rab1A | decreased actin filament polymerization | decreased chemotaxis to cAMP |
| DBS0351443 | [unk]: GFP: RasG(G12T) | rasG | increased macropinocytosis |
| DBS0351445 | [unk]: GFP: RasS(G12V) | rasS | increased macropinocytosis |
| DBS0350558 | [unk]: pikI(T262E) | pikI | increased catalytic activity |
| DBS0350258 | [unk]: rapA(G12V) | rapA | increased activation of GTPase activity |
| DBS0236859 | [unk]: rasD(G12T) | rasD | increased myo-inositol level | decreased gene expression | increased prestalk gene expression | decreased prespore gene expression | development arrests at tipped mound stage | increased protein kinase activation |
| DBS0350837 | [unk]: rasD(G12T)/ [rasD]: rapA | rapA | rasD | increased number of mound tips | aberrant culmination | decreased prespore cell differentiation | aberrant gene expression | decreased stalk cell differentiation |
| DBS0304636 | [unk]: rasG(Q61L)/ rasG- | rasG | aberrant extracellular cAMP signaling pathway | increased protein modification |
| DBS0350056 | [unk]: tubA: GFP/ RNAi]cepG | cepG | tubA | aberrant cytokinesis | aberrant microtubule cytoskeleton organization | aberrant protein localization to nuclear envelope | aberrant centromere complex assembly |
| DBS0350913 | [unk]: tubA: GFP/ [RNAi]cepD | cepD | increased number of centrosomes | aberrant mitotic spindle organization | decreased protein localization to microtubule organizing center |
| DBS0351237 | [unk]: tubA: GFP/ [RNAi]cepL | cepL | tubA | decreased growth rate | aberrant cytokinesis | aberrant microtubule cytoskeleton organization | aberrant centromere complex assembly |
| DBS0350737 | acaA-/ [act15]: acaA | acaA | aberrant slug development |
| DBS0350723 | acrA-/ [act15]: acaA(L394S) | acaA | acrA | precocious spore germination |
| DBS0237786 | acrA-/ [act15]: acgA(1-401) | acgA | acrA | decreased prespore gene expression | decreased prespore cell differentiation | decreased sporulation |
| DBS0351576 | atg5-/ abpB-/ [dscB]: abpB(D93A/ D95A/ D97A): GFP | abpB | atg5 | aberrant cellular component organization | abolished vegetative growth |
| DBS0351477 | atg7-/ [act15]: YFP: atg7(C563A) | atg7 | aberrant sorus morphology | decreased spore germination | delayed development |
| DBS0350437 | cdk8-/ [act15]: myc: cdk8(D194A) | cdk8 | decreased spore germination | abolished aggregation |
| DBS0350343 | corA-/ [act15]: GFP: pakA(797-1197) | corA | pakA | wild type |
| DBS0237568 | ctxA-/ [RNAi]enlA | ctxA | enlA | wild type |
| DBS0235560 | dagA-/ acaA(L394S) | acaA | dagA | wild type |
| DBS0302601 | dsgg-/ [OE]: dsgg(Q551A) | dsgg | aberrant contractile vacuole organization |
| DBS0302600 | dsgg-/ [OE]: dsggR515A) | dsgg | aberrant contractile vacuole organization |
| DBS0304913 | gbpC-/ [act15]: gbpC(K342N) | gbpC | decreased chemotaxis to cAMP |
| DBS0304914 | gbpC-/ [act15]: gbpC(K905W) | gbpC | decreased chemotaxis to cAMP |
| DBS0237190 | gdt1-/ [act15]: pkaR(G135E/ G261A) | gdt1 | pkaR | increased gene expression | abolished aggregation |
| DBS0350449 | gefA-/ [dscB]: rasG(S17N) | gefA | rasG | decreased actin filament polymerization | decreased activation of GTPase activity | aberrant chemotaxis to cAMP | decreased protein kinase activation |
| DBS0236092 | gpaA-/ [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0236093 | gpaA-/ [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0351214 | gpaB-/ [act15]: rasG(S17N) | gpaB | rasG | abolished activation of GTPase activity |
| DBS0350608 | gpaD-/ [act15]: gpaD(Q200L) | gpaD | development arrests at loose mound stage | decreased chemotaxis to folate | decreased protein kinase activation |
| HO547 | gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP | gpbA | aberrant cortical actin cytoskeleton organization |
| HO543 | gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: YFP: FKBP | gpbA | abolished chemotaxis to folate |
| DBS0350832 | gpbA-/ [unk]: gpbA(Q208L) | gpbA | aberrant adaptation of signaling pathway |
| DBS0350427 | gskA-/ gskA(K85R): GFP | gskA | aberrant aggregation |
| DBS0350348 | gtaC-/ [act15]: GFP: gtaC | gtaC | wild type |
| DBS0266892 | gtaC-KD | gtaC | abolished stalk cell differentiation |
| DBS0266893 | gtaC-KD/ [act15]: GFP: gtaC | gtaC | wild type |
| DBS0351436 | ireA-/ [act15]: ireA(K603N): GFP | ireA | decreased protein level | aberrant endoplasmic reticulum organization | aberrant cellular response to stress |
| DBS0351437 | ireA-/ [act15]: ireA(N927A): GFP | ireA | decreased protein level | aberrant endoplasmic reticulum organization | aberrant cellular response to stress |
| DBS0350057 | keaA- | keaA | aberrant extracellular cAMP signaling pathway | decreased gene expression | delayed aggregation | decreased growth rate | decreased cAMP level |
| DBS0350947 | kif8-/ [act15]: dhcA(1384-4725) | dhcA | kif8 | wild type |
| DBS0350599 | krsB-/ [tet]: krsB(T176A): GFP | krsB | aberrant stream morphology |
| DBS0350114 | lst8-/ [act15]: GFP: rheb(Q64L) | lst8 | rheb | increased phagocytosis |
| DBS0350567 | lvsB-/ [act15]: FLAG: Rab14(N121I) | lvsB | rab14 | wild type |
| DBS0350032 | mekA-/ [act15]: mekA(S444A/ T448A) | mekA | decreased mound size |
| DBS0350031 | mekA-/ [act15]: mekA(S444E/ T448E) | mekA | development arrests at mound stage |
| DBS0237564 | mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA | ctxA | enlA | mhcA | aberrant mitotic actomyosin contractile ring contraction |
| DBS0350489 | mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1 | mhcA | rmd1 | abolished protein localization to cleavage furrow |
| DBS0238399 | mhcA-/ [act15]: rapA(G12V) | mhcA | rapA | increased establishment of cell polarity | increased actin filament polymerization | aberrant myosin II filament organization |
| DBS0351180 | midA/ [act15]: midA(E200A) | midA | aberrant cellular homeostasis | decreased growth rate | decreased phototaxis |
| DBS0351182 | midA/ [act15]: midA(G170V/ G172V) | midA | aberrant cellular homeostasis | decreased growth rate | decreased phototaxis |
| DBS0351181 | midA/ [act15]: midA(N205A) | midA | aberrant cellular homeostasis | decreased growth rate | decreased phototaxis |
| DBS0304881 | mrps4- | mrps4 | delayed aggregation |
| DBS0304882 | mtDNA- | DidioMp05 | DidioMp21 | DidioMp26 | DidioMp27 | DidioMp30 | DidioMp35 | DidioMp36 | ai2a | ai2b | ai3 | ai4 | atp1 | atp4 | atp6 | atp8 | atp9 | cox1/ 2 | cox3 | cytB | mrpl11 | mrpl14 | mrpl16 | mrpl2 | mrpl6 | mrps12 | mrps13 | mrps14 | mrps19 | mrps2 | mrps4 | mrps7 | mrps8 | nad1 | nad11 | nad2 | nad3 | nad4 | nad4L | nad5 | nad6 | nad7 | nad9 | rnlA | abolished vegetative growth | abolished aggregation |
| DBS0236583 | myoB-/ [AS]myoD | myoB | myoD | decreased pinocytosis | aberrant aggregation | decreased growth rate | decreased phagocytosis | decreased mound size | decreased cell motility |
| DBS0236584 | myoB-/ [AS]myoD/ [KD]myoC | myoB | myoC | myoD | decreased pinocytosis | aberrant aggregation | decreased pinosome size | decreased growth rate | decreased phagocytosis | decreased mound size | decreased cell motility | increased number of pinosomes |
| DBS0349854 | myoK-/ [act15]: pakB(1-337: 563-852) | myoK | pakB | wild type |
| DBS0350137 | ndufaf5-/ [act15]: [AS]snfA | ndufaf5 | snfA | aberrant phototaxis |
| DBS0350006 | nhe1-/ [act15]: GFP: aip1(E125A, E167A, F181A, F193A) | aip1 | nhe1 | abolished aggregation | abolished chemotaxis to cAMP |
| DBS0350810 | pakA-/ [act15]: pakA(T579A) | pakA | decreased chemotaxis to cAMP |
| DBS0350113 | pkbA-/ [act15]: GFP: rheb(Q64L) | pkbA | rheb | decreased phagocytosis |
| DBS0236789 | pkgB-/ [act15]: pkgB(K182M) | pkgB | development arrests at mound stage |
| DBS0350306 | psenA-/ psenB-/ [act15]: psenB(D348A/ D394A) | psenA | psenB | wild type |
| DBS0302357 | psrA-/ [act15]: gskA(K84M/ K85M) | gskA | psrA | decreased culmination | decreased prespore gene expression | delayed development | increased protein kinase activation |
| DBS0350829 | psrA-/ [unk]: FLAG: rasD(G12T) | psrA | rasD | increased protein kinase activation |
| DBS0349893 | pten-/ pakA-/ [act15]: pakA(T585A): GFP | pakA | pten | decreased chemotaxis to cAMP |
| DBS0349900 | pten-/ pakA-/ [act15]: pakA(T585E): GFP | pakA | pten | aberrant cytokinesis | decreased chemotaxis to cAMP |
| DBS0351348 | racE-/ [act15]: GFP: racE(G20V) | racE | decreased protein phosphorylation | decreased chemotaxis to cAMP |
| DBS0351351 | racE-/ [act15]: GFP: rasC(Q62L) | racE | rasC | decreased protein phosphorylation |
| DBS0350956 | racE-/ [act15]racE(G20V) | racE | wild type |
| DBS0351213 | rasC-[act15]: rasG(S17N) | rasC | rasG | abolished activation of GTPase activity | decreased chemotaxis to cAMP |
| DBS0350448 | rasG-/ [dscB]: rasG(S17N) | rasG | decreased positive regulation of GTPase activity | decreased actin filament polymerization | decreased protein kinase activation | decreased chemotaxis to cAMP |
| DBS0236884 | rckA-/ [act15]: myc: rckA(K867A) | rckA | development arrests at mound stage | decreased chemotaxis rate |
| DBS0350770 | ripA-/ [act15]: GFP: rapA(G12V) | rapA | ripA | decreased protein kinase activation |
| DBS0350115 | ripA-/ [act15]: GFP: rheb(Q64L) | rheb | ripA | increased phagocytosis |
| DBS0350189 | rrpA-/ rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ | rrpA | rrpB | rrpC | abolished transitive RNA interference |
| DBS0350187 | rrpA-/ rrpC-/ [act6]: lacZ/ [AS]lacZ | rrpA | rrpC | aberrant production of siRNA involved in RNA interference |
| DBS0350182 | rrpA-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ | rrpA | rrpC | abolished transitive RNA interference |
| DBS0350185 | rrpB-/ rrpC-/ [act6]: lacZ/ [AS]lacZ | rrpB | rrpC | aberrant production of siRNA involved in RNA interference |
| DBS0350184 | rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ | rrpB | rrpC | abolished transitive RNA interference |
| DBS0350216 | rrpC-/ [act6]: LacZ/ [RNAi]lacZ | rrpC | abolished transitive RNA interference |
| DBS0350217 | rrpC-/ [act6]: lacZ/ [AS]lacZ | rrpC | aberrant production of siRNA involved in RNA interference |
| DBS0351564 | sbdS(1-30,TS18,31-274) | sbds | development arrests at loose mound stage | aberrant cellular process | abolished vegetative growth |
| DBS0350063 | scrA-/ [tet]: scrA/ mhcA- | mhcA | scrA | aberrant cytokinesis |
| DBS0351610 | scrA-/ [tet]: scrA/ wasA- | scrA | wasA | aberrant cell motility | abolished vegetative growth | abolished bleb assembly | aberrant pseudopodium formation |
| DBS0349941 | sunB- | sunB | increased number of tip-organizers | aberrant cytokinesis |
| DBS0238395 | talA-/ [act15]: rapA(G12V) | rapA | talA | increased cell-substrate adhesion |
| DBS0302382 | tsuA-/ [unk]: tsuA(K34R): YFP | tsuA | decreased mound size | decreased fruiting body size |
| DBS0237051 | wasA- | wasA | decreased cell motility | delayed development | aberrant actin filament organization |
| DBS0351509 | wasA-/ [tet]: scrA/ [unk]: GFP: wasA(I173A/ F179A) | scrA | wasA | aberrant pseudopodium formation |
| DBS0237052 | wasA1-/ [tet]: YFP: wasA2 | wasA | decreased actin filament polymerization | abolished positive chemotaxis | abolished aggregation | aberrant actin filament organization |
| DBS0237811 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA(Y33A/ W39A/ F90A/ F91A) | wasA | decreased actin filament polymerization | decreased actin filament polymerization at leading edge |
| DBS0237820 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wipA | wasA | wipA | abolished positive chemotaxis |
| DBS0350058 | yakA-/ keaA- | keaA | yakA | wild type |
BACK TO TOP - BACK TO DOWNLOADS INDEX
| Home| Contact dictyBase| SOPs| Site Map |
Supported by NIH (NIGMS and NHGRI)
|
